Hematology and Infectious Disease Prevention
Clinical research in patients with acute leukemia and recipients of hematopoietic stem cell transplantation focuses on reducing the risk of febrile neutropenia and infection during periods of severe immune suppression. The sponsor’s activity in this area is centered on supportive care for high-risk hematologic patients.
- Febrile neutropenia
- Acute leukemia
- Hematopoietic stem cell transplantation
- Antibacterial prophylaxis
This area includes oral antibacterial strategies used in the prevention of infection-related complications in hematology and transplantation settings.
Peripheral Arterial Disease and Critical Limb Ischemia
Research activity also addresses advanced chronic ischemia with severe limb threat, including patients at risk of amputation. The therapeutic focus is on vascular and regenerative approaches for individuals with limited conventional treatment options.
- Critical limb ischemia
- Peripheral arterial disease
- Limb salvage
- Autologous bone marrow-derived cells
These studies reflect interest in restoring perfusion, improving pain and function, and preserving affected limbs in advanced vascular disease.
Wound Healing and Regenerative Medicine
The sponsor funds research in hard-to-heal wounds, including approaches that use stem cells within local wound treatments. This area is directed toward chronic tissue repair and support of wound closure in patients with persistent skin and soft-tissue damage.
- Chronic wounds
- Stem cell-based wound care
- Tissue regeneration
- Local wound therapy
Work in this field is linked to improving healing in wounds that remain resistant to standard care.
